Review
Published on 03 Feb 2025
Natural products targeting AMPK signaling pathway therapy, diabetes mellitus and its complications
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534634
- 585 views
Type at least 3 characters
25,494 articles
Articles
Policy and Practice Reviews
Published on 03 Feb 2025
Climate change and the sustainable use of medicinal plants: a call for “new” research strategies
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1496792
- 1,157 views
Systematic Review
Published on 03 Feb 2025
The role of statins in dementia or Alzheimer’s disease incidence: a systematic review and meta-analysis of cohort studies
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1473796
- 485 views
Original Research
Published on 03 Feb 2025
Conditional knockdown of hepatic PCSK9 ameliorates high-fat diet-induced liver inflammation in mice
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528250
- 419 views
Review
Published on 03 Feb 2025
Bioprinted hydrogels in bone regeneration: a bibliometric analysis
in Integrative and Regenerative Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1532629
- 557 views
Original Research
Published on 03 Feb 2025
Rutaecarpine alleviates hepatic ischemia‒reperfusion injury in liver transplantation by inhibiting inflammatory response and oxidative stress
in Gastrointestinal and Hepatic Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1539744
- 356 views
Systematic Review
Published on 03 Feb 2025
Comparative efficacy of topical commercial Chinese polyherbal preparation for vulvovaginal candidiasis: a network meta-analysis
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1484325
- 377 views
Original Research
Published on 03 Feb 2025
Gallic acid protects intervertebral disc cells from ferroptosis and alleviates intervertebral disc degeneration by regulating key factors of oxidative stress
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1501725
- 442 views
Original Research
Published on 03 Feb 2025
Leveraging AI to automate detection and quantification of extrachromosomal DNA to decode drug responses
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1516621
- 450 views
Original Research
Published on 03 Feb 2025
Discovery of novel and highly potent small molecule inhibitors targeting FLT3-ITD for the treatment of acute myeloid leukemia using structure-based virtual screening and biological evaluation
in Experimental Pharmacology and Drug Discovery
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1511257
- 389 views
Original Research
Published on 03 Feb 2025
ELABELA promotes the migration and homing of bone marrow mesenchymal stem cells to myocardial injury sites through the ERK1/2/miR-299a-5p/Exo70 pathway
in Integrative and Regenerative Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1541869
- 380 views
Systematic Review
Published on 03 Feb 2025
Angel or devil: the dual roles of 2,3,5,4′-tetrahydroxystilbene-2-O-β-D-glucopyranoside in the development of liver injury based on integrating pharmacological techniques: a systematic review
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1523713
- 486 views
Review
Accepted on 31 Jan 2025
Formononetin: A review of its source, pharmacology, drug combination, tox icity, derivatives, and drug delivery systems
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1534798
Review
Accepted on 31 Jan 2025
Berberine and its Derivatives: Mechanisms of Action in Myocardial Vascular Endothelial Injury -A Review
in Cardiovascular and Smooth Muscle Pharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1543697
Original Research
Published on 31 Jan 2025
Targeted ErbB4 receptor activation prevents D-galactose-induced neuronal senescence via inhibiting ferroptosis pathway
in Neuropharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1528604
- 629 views
Original Research
Published on 31 Jan 2025
Hu-lu-su-pian ameliorates hepatic steatosis by regulating CIDEA expression in AKT-driven MASLD mice
in Ethnopharmacology
Frontiers in Pharmacology
doi 10.3389/fphar.2024.1503247
- 551 views